1. Hurlen M et al.Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002; 347:969 2. Ascani A et al: “Withdrawal of warfarin after deep vein thrombosis: effect of low fixed doses on rebound trhrombin generation”. Blood Coagul Fibrinolisys 1999; 10: 291-95 3. Van Dongen CJJ et al. The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event. A Meta-analysis. Arch Intern Med. 2003; Jun 09; 163:1285-1293 4. Ridker PM et al. Long-term, low-intensity Warfarin Therapy for he Prevention of Recurrent Venous Thromboembolism. N Engl J Med 2003; 348:1425-1434 5. Baglin T et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-26 6. Lubetsky A. et al. Comparison of Oral vs Intravenous Phytonadione (Vitamin K1) in Patients With Excessive Anticoagulation.A Prospective Randomized Controlled Study. Arch Intern Med. 2003; Nov 10; 163:2469-2473. 7. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003;110: 1784-8 8. Cannon PD, Dharmar VT. Minor oral surgical procedures in patients on oral anticoagulants - a controlled study. Aust Dent J 2003;48:115-8. 9. Cromheecke ME et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomized cross-over comparison. Lancet 2000; 356:97-102 10. Murray E et al. Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ 2004; 328:437-438 11. FCSA-SIMG. Guida alla terapia anticoagulante orale per medici di medicina generale, 2000. www.simg.areacv.it 12. Odén A and Fahlén M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002 Nov 9; 325:1073-1075 13. van Es RF et al. Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis–2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 2002;360:109-113. 14. Medical Research Council. Randomized trial of low intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischemic heart disease in men at increased risk: the Medical Research Council's General Practice Research Framework Thrombosis Prevention Trial. Lancet. 1998; 351:233-241. 15. Torn M et al. Lowering the intensity of oral anticoagulant therapy. Effects on the risck of hemorrhage and thromboembolism. Arch Intern Med 2004 March 22;164:668-673. 16. Scottish Intercollegiate Guidelines Network. Antithrombotic Therapy. SIGN Pubblication n. 36. March 1999. www.show.scot.nhs.uk/sign/index.html 17. Bárbara Menéndez-Jándula B et al. Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management . A Randomized Trial. Ann Intern Med 2005 Jan 4; 142: 1-10 18. Torn M et al. Risks of Oral Anticoagulant Therapy With Increasing Age. Arch Intern Med. 2005 Jul 11; 165:1527-1532. 19. Fitzmaurice DA et al. Self management of oral anticoagulation: randomized trial. BMJ 2005 Nov 5; 331:1057 20. http://www.medscape.com/viewarticle/523638?sssdmh=dm1.181753&src=nldne 21. DeZee KJ et al. Treatment of Excessive Anticoagulation With Phytonadione (Vitamin K). A Meta-analysis. Arch Intern Med. 2006 Feb 27; 166:391-397. 22. Heneghan C et al. Self-monitoring of oral anticoagulation: A systematic review and meta-analysis. Lancet 2006 Feb 4; 367:404-11. 23. Garcia D, et al. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. June 2005;127:2049-56 24. Dentali F et al. Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease. A Meta-analysis of Randomized Trials. Arch Intern Med. 2007 Jan 22;167:117-124. 25. The Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 2007 Jul 19; 357:217-27. 26. Crowther MA et al. Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. A Randomized Trial. Ann Intern Med 2009 Mar 3; 150:293-300.
|
|
